AU1165899A - Conjugates comprising two active agents - Google Patents

Conjugates comprising two active agents

Info

Publication number
AU1165899A
AU1165899A AU11658/99A AU1165899A AU1165899A AU 1165899 A AU1165899 A AU 1165899A AU 11658/99 A AU11658/99 A AU 11658/99A AU 1165899 A AU1165899 A AU 1165899A AU 1165899 A AU1165899 A AU 1165899A
Authority
AU
Australia
Prior art keywords
active agents
conjugates
carrier
linker
functional group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11658/99A
Other languages
English (en)
Inventor
Nicola Jane Church
Roy Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Healthcare UK Ltd
Original Assignee
Quadrant Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadrant Healthcare UK Ltd filed Critical Quadrant Healthcare UK Ltd
Publication of AU1165899A publication Critical patent/AU1165899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU11658/99A 1997-11-14 1998-11-16 Conjugates comprising two active agents Abandoned AU1165899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9724143 1997-11-14
GBGB9724143.4A GB9724143D0 (en) 1997-11-14 1997-11-14 Pharmaceutical conjugate
PCT/GB1998/003442 WO1999025383A1 (en) 1997-11-14 1998-11-16 Conjugates comprising two active agents

Publications (1)

Publication Number Publication Date
AU1165899A true AU1165899A (en) 1999-06-07

Family

ID=10822123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11658/99A Abandoned AU1165899A (en) 1997-11-14 1998-11-16 Conjugates comprising two active agents

Country Status (9)

Country Link
US (1) US7001989B2 (cg-RX-API-DMAC10.html)
EP (1) EP1047452B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001523648A (cg-RX-API-DMAC10.html)
AT (1) ATE293459T1 (cg-RX-API-DMAC10.html)
AU (1) AU1165899A (cg-RX-API-DMAC10.html)
DE (1) DE69829880T2 (cg-RX-API-DMAC10.html)
ES (1) ES2238774T3 (cg-RX-API-DMAC10.html)
GB (1) GB9724143D0 (cg-RX-API-DMAC10.html)
WO (1) WO1999025383A1 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933366B2 (en) * 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
EP1089762A1 (de) * 1998-06-10 2001-04-11 Baxter Aktiengesellschaft Konjugat, bestehend aus einem lektin und einem blutgerinnungsfaktor
GB9825105D0 (en) * 1998-11-16 1999-01-13 Andaris Ltd Pharamaceutical conjugates
GB9827813D0 (en) * 1998-12-17 1999-02-10 Andaris Ltd Pharmaceutical conjugates
DE19926475A1 (de) * 1999-06-10 2000-12-14 Ktb Tumorforschungs Gmbh Träger-Pharmaka-Konjugate
WO2001008709A1 (en) * 1999-07-28 2001-02-08 Valentis, Inc. Sonoporation of tumors
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
ES2525585T3 (es) 2006-05-05 2014-12-26 The Regents Of The University Of Michigan Intermedios para la preparación de miméticos de SMAC bivalentes
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US20090170195A1 (en) * 2007-12-28 2009-07-02 Kent State University Curcumin-hyaluronan compounds
US20110077202A1 (en) * 2008-05-16 2011-03-31 Bayer Healthcare Llc Targeted Coagulation Factors and Method of Using the Same
ES2427627T3 (es) * 2009-04-06 2013-10-31 Novo Nordisk A/S Entrega dirigida de proteínas de Factor VIII a plaquetas
GB201101740D0 (en) * 2011-02-01 2011-03-16 Haemostatix Ltd Therapeutic agents with improved fibrinogen binding

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970300A (en) * 1985-02-01 1990-11-13 New York University Modified factor VIII
IL85372A (en) * 1987-02-12 1992-12-01 Us Health Penta to nona-peptides with laminin - like activity having an amino acid sequence and anti- metastatic compositions containing them
US5716614A (en) 1994-08-05 1998-02-10 Molecular/Structural Biotechnologies, Inc. Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
DE69529917T2 (de) * 1994-12-16 2003-12-11 Elan Drug Delivery Ltd., Ruddington Vernetzte mikropartikel und ihre verwendung als arzneiträger
EP0831793A4 (en) 1995-06-06 2000-11-15 Hemosphere Inc PROTEIN PARTICLES FOR THERAPEUTIC AND DIAGNOSTIC USE
AU718956B2 (en) 1996-10-21 2000-05-04 Quadrant Healthcare (Uk) Limited Platelet substitutes and conjugation methods suitable for their preparation

Also Published As

Publication number Publication date
EP1047452A1 (en) 2000-11-02
WO1999025383A1 (en) 1999-05-27
GB9724143D0 (en) 1998-01-14
DE69829880T2 (de) 2005-09-22
US7001989B2 (en) 2006-02-21
EP1047452B1 (en) 2005-04-20
ES2238774T3 (es) 2005-09-01
DE69829880D1 (de) 2005-05-25
ATE293459T1 (de) 2005-05-15
JP2001523648A (ja) 2001-11-27
US20030087826A1 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
GB9724143D0 (en) Pharmaceutical conjugate
EP1374908A3 (en) Polymer-drug conjugates comprising hydrazide linkers
IL131651A0 (en) A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same
IL135148A0 (en) A polysaccharide conjugate and pharmaceutical compositions containing the same
CA2309818A1 (en) Buffered drug formulations for transdermal electrotransport delivery
CA2166931A1 (en) Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon
ATE369878T1 (de) Träger-pharmaka-konjugate
PT1176961E (pt) Sistemas de administracao de nicotina
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
MX9603570A (es) Metodo y composiciones para incrementar la vida media en suero de agentes farmacologicamente activos.
AU7667398A (en) Integrin-targeting vectors having transfection activity
CA2280875A1 (en) Remedies for lymphocytic tumors
DE69707870D1 (de) Quartäre cytofectine
ZA981029B (en) Pharmaceutical agents.
SG168401A1 (en) Catalyst and use thereof
BR9808770A (pt) Conjugado medicamentoso, método para suaprodução e seu uso
AU2460499A (en) Vanadium (iv) metallocene complexes having spermicidal activity
UA32522C2 (uk) Ліофілізована протипухлинна композиція і стерильна водна композиція для ін'єкцій на її основі
CA2300089A1 (en) Safety support
DE60041351D1 (de) Gssytem
DK0815141T3 (da) Antistof mod et fusionspolypeptid omfattende en histidinandel
ES2183346T3 (es) Sistemas conjugados de bis-fosfonato con restos alquilantes que tienen actividad antitumoral.
PT1150716E (pt) Composicao farmaceutica de proteinas hedgehog hidrofobicamente modificadas e sua utilizacao
DE69830333D1 (de) SCHNELLÖSLICHE ARZNEIMITTELZUSAMMENSETZUNG ENTHALTEND MIKRONISiERTE AS-3201

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase